Bright Minds Biosciences ... (DRUG)
36.82
1.58 (4.48%)
At close: Jan 15, 2025, 11:49 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -2.80M | -7.37M | -14.96M | -8.65M | -480.38K | -78.72K |
| Depreciation & Amortization | 73.36K | 72.45K | 6.04K | n/a | n/a | n/a |
| Stock-Based Compensation | 839.77K | 1.15M | 875.06K | 880.62K | 161.30K | n/a |
| Other Working Capital | 53.06K | -941.72K | 771.94K | 416.23K | 30.68K | 36.71K |
| Other Non-Cash Items | -1.18K | 65.10K | -229.57K | 144.76K | 161.30K | 110.12K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 39.81K | -941.72K | 726.31K | 306.08K | 30.68K | 36.71K |
| Operating Cash Flow | -1.85M | -7.02M | -13.59M | -7.32M | -288.39K | -42.01K |
| Capital Expenditures | n/a | 5.00 | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt Repayment | -89.73K | -86.11K | -7.16K | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 302.00 | 1.06M | 1.17M | -1.69M | n/a | 366.00K |
| Financial Cash Flow | 810.57K | 2.19M | 5.20M | 26.06M | 1.01M | 122.00K |
| Net Cash Flow | -1.03M | -4.88M | -8.13M | 18.96M | 719.94K | 79.99K |
| Free Cash Flow | -1.85M | -7.02M | -13.59M | -7.32M | -288.39K | -42.01K |